TriunityCX is a North Carolina based health technology company founded to address two problems that the healthcare industry has treated as separate for too long: the financial strain that hospital readmissions place on health systems, and the evidence gap that limits what pharmaceutical companies can know about how their drugs perform in the real world.
TriunityCX was founded on the belief that the structural misalignment between health systems, pharmaceutical companies, and patients is not inevitable. Health systems are penalized for readmissions that occur after patients leave their walls, in a window where they have no visibility and no mechanism to intervene. Pharmaceutical companies are building commercial and regulatory strategies on evidence that was never designed to capture what happens in that same window. Patients are navigating the most vulnerable period of their recovery without structured support.
Trisana addresses all three of those failures simultaneously through a business model that makes each stakeholder's success dependent on the others.
TriunityCX envisions a healthcare system in which health systems have real time visibility into what is happening to their patients after discharge and the operational infrastructure to intervene before a readmission occurs. Where pharmaceutical companies have access to behavioral and social evidence that reflects how their drugs actually perform in the real world, not how they performed in a controlled trial environment. And where patients in the most vulnerable period of their recovery receive structured support regardless of the resources of the hospital that treated them or the community they return to.
Trisana is the infrastructure that makes that possible, starting with heart failure and expanding across every high readmission condition where the post discharge window determines whether a patient recovers or returns.
TriunityCX is headquartered in Durham, North Carolina, and is committed to building its initial hospital network in the state that shaped the company. North Carolina's community and rural hospital systems face some of the most acute financial pressure in the country, driven by above average SDOH burden, high chronic disease prevalence in rural communities, and the compounding effects of federal Medicaid policy changes on facilities already operating with thin margins.
The Research Triangle's concentration of pharmaceutical, biotech, and academic medical institutions also makes North Carolina a natural home for the evidence intelligence side of the Trisana model. The UNC Sheps Center for Health Services Research, Duke Health, and the broader Triangle health innovation ecosystem provide a context in which the High Fidelity Patient Evidence framework can be developed, validated, and eventually published in a peer reviewed context.
A zero cost post discharge management program that reduces readmissions makes the most immediate difference in the hospital systems that need it most: community and rural facilities that lack the resources to build this infrastructure on their own. North Carolina has 130 acute care hospitals, the majority of which fit that profile exactly.
Whether you are a health system administrator exploring post discharge patient management solutions, a pharmaceutical professional interested in a new category of real world evidence, or an investor or collaborator interested in what TriunityCX is building, we welcome the conversation.